Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring

In light of COVID-19, reducing patient exposure via remote monitoring is desirable. Patients prescribed abiraterone/ enzalutamide are scheduled for monthly in-person appointments to screen for adverse events (AEs). We determined time trends of drug-specific actionable AEs among users of abiraterone/enzalutamide to assess the safety of remote monitoring.A chart review was conducted on 828 prostate cancer patients prescribed abiraterone and/or...